Abrdn Healthcare Investors

HQH

US87911J1034

Closed End Funds

Real-time Estimate Cboe BZX Other stock markets 14:44:50 10/06/2024 BST			5-day change	1st Jan Change
16.98 ^USD	+0.21%		+1.37%	+2.60%

2023	Abrdn Healthcare Investors Reports Earnings Results for the Full Year Ended September 30, 2023	CI
2023	Tekla Healthcare Investors Insider Bought Shares Worth $148,515, According to a Recent SEC Filing	MT

Tekla Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2019

June 05, 2019 at 07:41 pm

Tekla Healthcare Investors announced earnings results for the half year ended March 31, 2019. For the half year, the company announced total revenue was USD 3.710 million. Net loss was USD 84.394 million.

Latest news about Abrdn Healthcare Investors

Abrdn Healthcare Investors Reports Earnings Results for the Full Year Ended September 30, 2023	12-11	CI
Tekla Healthcare Investors Insider Bought Shares Worth $148,515, According to a Recent SEC Filing	25/09/23	MT
Tekla Life Sciences Investors, Tekla Healthcare Opportunities Fund, Tekla World Healthcare Fund and Tekla Healthcare Investors Approves Election of Rose Dimartino, C. William Maher, Todd Reit and Stephen Bird as New Trustees	22/08/23	CI
Tekla Healthcare Investors Declares Distribution, Payable on September 29, 2023	15/08/23	CI
Tekla Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2023	06/06/23	CI
Tekla Healthcare Investors Declares Distribution, Payable Date Is June 30, 2023	15/05/23	CI
Tekla Healthcare Investors Declare Dividend, Payable on March 31, 2023	15/02/23	CI
Tekla Healthcare Investors Reports Earnings Results for the Full Year Ended September 30, 2022	07/12/22	CI
Tekla Healthcare Investors Declares Distribution, Payable December 30, 2022	15/11/22	CI
Tekla Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2022	03/06/22	CI
Tekla Healthcare Investors Declares Distribution, Payable on June 30, 2022	17/05/22	CI
Tekla Healthcare Investors Renews Share Buyback Program	22/03/22	MT
Tekla Healthcare Investors authorizes a Buyback Plan.	22/03/22	CI
Tekla Healthcare Investors announces an Equity Buyback for 12% of its outstanding shares.	22/03/22	CI
Tekla Healthcare Investors Declares Distribution, Payable on March 31, 2022	15/02/22	CI
Top Premarket Decliners	07/12/21	MT
Tekla Healthcare Investors Reports Earnings Results for the Full Year Ended September 30, 2021	03/12/21	CI
Tekla Healthcare Investors Declares Distribution, Payable on December 31, 2021	12/11/21	CI
Tekla Healthcare Investors Declares Distribution, Payable on September 30, 2021	17/08/21	CI
Tekla Healthcare Investors Declares Stock Distribution, Payable on June 30, 2021	18/05/21	CI
Tekla Healthcare Investors Declares Distribution, Payable on March 31, 2021	16/02/21	CI
Tekla Healthcare Investors Declares Special Cash Distribution, Payable on January 6, 2021	21/12/20	CI
Tekla Healthcare Investors Declares Distribution, Payable on December 31, 2020	16/11/20	CI
Tekla Healthcare Investors Declares Stock Distribution, Payable on September 30, 2020	17/08/20	CI
Tekla Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2020	05/06/20	CI

Chart Abrdn Healthcare Investors

Duration

Period

More charts

Company Profile

abrdn Healthcare Investors (the Fund), formerly Tekla Healthcare Investors, is a non-diversified closed-end healthcare fund. The Fund's investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. In addition, it seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets. It invests in healthcare industries and is focused on the smaller, emerging companies, investing a maximum of 40% of the Fund's assets in restricted securities of both public and private companies. It invests in subsectors, such as biotechnology, pharmaceuticals, healthcare equipment, healthcare supplies, life science tools and services, healthcare distributors, managed healthcare and others. abrdn Inc. is the investment adviser of the Fund.

Sector

Closed End Funds

Calendar

24/06/2024 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Sector Closed End Funds

	1st Jan change	Capi.
ABRDN HEALTHCARE INVESTORS	+2.60%	858M
ARES CAPITAL CORPORATION	+7.71%	13.23B
PERSHING SQUARE HOLDINGS, LTD.	+15.52%	9.88B
FS KKR CAPITAL CORP.	+3.25%	5.77B
PIMCO DYNAMIC INCOME FUND	+8.05%	5.31B
SPROTT PHYSICAL SILVER TRUST	+23.32%	4.78B
SPROTT PHYSICAL URANIUM TRUST FUND	-7.93%	4.62B
SPROTT PHYSICAL GOLD AND SILVER TRUST	+19.31%	4.47B
MACQUARIE KOREA INFRASTRUCTURE FUND	+1.77%	4B
3I INFRASTRUCTURE PLC	+4.23%	3.98B

Closed End Funds

Abrdn Healthcare Investors

Equities

HQH

US87911J1034

Closed End Funds

Tekla Healthcare Investors Reports Earnings Results for the Half Year Ended March 31, 2019

Latest news about Abrdn Healthcare Investors

Chart Abrdn Healthcare Investors

Company Profile

Income Statement Evolution

Sector Closed End Funds